LB0006 SPACING OF A TNF BLOCKER AND DOSE REDUCTION OF METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS IN REMISSION OR LOW DISEASE ACTIVITY WITH OZORALIZUMAB AND METHOTREXATE: A RANDOMISED, CONTROLLED TRIAL (SORAIRO TRIAL)Yuki Imai, Yoko Kaneko, Taeko Ishii et al.|Annals of the Rheumatic Diseases|2025Cited by 0